MAS Drug Discovery and Clinical Development Objectives Provide essential business knowledge of drug and medical devices in clinical research and development Give health professionals the tools to comply with the highest scientific and ethical standards in clinical research Empower physicians and health scientists to lead clinical trials within hospitals, pharmaceutical and biotechnology companies Enable health professionals to gain a strategic vision of clinical development and navigate the complexities of bringing new medicinal products to the global market Audience Medical doctor, biologist, pharmacist, nurse, biochemist and other professional involved, or wishing to gain skills and knowledge, in the field of drug discovery and development Programme 12 modules: Introduction to Clinical Development: Challenges and Prospects • Principles and Methods of Clinical Research • Ethical and Legal Aspects • Preclinical Pharmacology, Toxicology and Clinical Pharmacology • Safety Management and Drug Development • Medical Statistics and TrialMethodologies • Clinical Trials Set-up and Conduct part 1 • Clinical Trials Set-up and Conduct part 2 • Regulatory Considerations in Drug Development • Duration ClinicalTrials Close-out and Reporting • Audits and Inspections • New Perspectives, September 2018-June 2019 Personalized Medicine and New Therapeutics • Thesis Every 2 years Directors 60 ECTS credits Prof. Jules DESMEULES, Faculty of Medicine, University of Geneva and Dr. François CURTIN, GeNeuro Registration Deadline 15 June 2018 Co-ordinator Modules can be followed individually Dr. Victoria ROLLASON, University of Geneva Information Accreditation/Recognition/Certification DAS.Clinicaltrials@hcuge.ch This programme is accredited by Swissethics, Swiss Association of Pharmaceutical +41 (0)22 372 99 34 Professionals, Swiss Society of Clinical Pharmacology and Toxicology, Swiss Institute for unige.ch/formcont/MASdrugdevelopment postgraduate and continuous medical education 212 santé Université de Genève